Home 5 Articles 5 CMS Recognizes 3 New CLIA-Waived (CW) Tests

CMS Recognizes 3 New CLIA-Waived (CW) Tests

by | Dec 16, 2021 | Articles, CMS-nir, Essential, National Lab Reporter, Recent Headlines, Reimbursement-nir

CMS announced three new CLIA-waived complexity tests that labs will be allowed to bill to Medicare, effective January 3, 2022. Here are the key details you need to know to ensure maximum reimbursement and proper billing. Billing of New CLIA-Waived Tests CLIA regulations require labs to be appropriately certified for each test they perform. CMS edits lab claims at the CLIA certificate level to ensure that Medicare pays only for lab tests categorized as waived complexity under CLIA in facilities with a CLIA certificate of waiver. QW Modifier Tests: The CPT codes for the following new tests, 80305, must have the modifier QW to be recognized as a waived test: 87801QW, March 30, 2021, binx health io Instrument (for use with female vaginal swabs and male urine) 86308QW, August 9, 2021, Cardinal Health MONO Rapid Test (whole blood) 87801QW, August 26, 2021, Visby Medical Sexual Health Click Test (for use with self-collected vaginal swabs). Non-QW Modifier Tests: The CPT codes for the following new tests, all of which are produced by various manufacturers, don’t need a QW modifier to be recognized as a waived test: CPT Code Name Use 81002 Dipstick or tablet reagent urinalysis—non-automated for bilirubin, glucose, hemoglobin, ketone, […]

CMS announced three new CLIA-waived complexity tests that labs will be allowed to bill to Medicare, effective January 3, 2022. Here are the key details you need to know to ensure maximum reimbursement and proper billing.

Billing of New CLIA-Waived Tests

CLIA regulations require labs to be appropriately certified for each test they perform. CMS edits lab claims at the CLIA certificate level to ensure that Medicare pays only for lab tests categorized as waived complexity under CLIA in facilities with a CLIA certificate of waiver.

QW Modifier Tests: The CPT codes for the following new tests, 80305, must have the modifier QW to be recognized as a waived test:

  • 87801QW, March 30, 2021, binx health io Instrument (for use with female vaginal swabs and male urine)
  • 86308QW, August 9, 2021, Cardinal Health MONO Rapid Test (whole blood)
  • 87801QW, August 26, 2021, Visby Medical Sexual Health Click Test (for use with self-collected vaginal swabs).

Non-QW Modifier Tests: The CPT codes for the following new tests, all of which are produced by various manufacturers, don’t need a QW modifier to be recognized as a waived test:

CPT Code Name Use
81002 Dipstick or tablet reagent urinalysis—non-automated for bilirubin, glucose, hemoglobin, ketone, leukocytes, nitrite, pH, protein, specific gravity, and urobilinogen Screening of urine to monitor/diagnose various diseases/conditions, such as diabetes, the state of the kidney or urinary tract, and urinary tract infections
81025 Urine pregnancy tests by visual color comparison Diagnosis of pregnancy
82270

82272

(Contact your Medicare carrier for claims instructions)

Fecal occult blood Detection of blood in feces from whatever cause, benign or malignant (colorectal cancer screening)
82962 Blood glucose by glucose monitoring devices cleared by FDA for home use Monitoring of blood glucose levels
83026 Hemoglobin by copper sulfate – nonautomated Monitor hemoglobin level in blood
84830 Ovulation tests by visual color comparison for human luteinizing
hormone
Detection of ovulation (optimal for conception)
85013 Blood count; spun microhematocrit Screen for anemia
85651 Erythrocyte sedimentation rate – nonautomated Nonspecific screening test for inflammatory activity, increased for
majority of infections, and most cases of carcinoma and leukemia

Subscribe to view Essential

Start a Free Trial for immediate access to this article